bupropion has been researched along with Opioid-Related Disorders in 13 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the United States there are medications available to treat tobacco use disorders (nicotine replacement, bupropion, and varenicline), alcohol use disorders (naltrexone and acamprosate), and opioid use disorders (methadone and buprenorphine)." | 4.93 | Pharmacotherapy for Substance Use Disorders. ( Klein, JW, 2016) |
| " In this commentary, we briefly summarize the extant literature on pharmacotherapies in opioid-maintained smokers and contribute new data investigating the contribution of bupropion on smoking outcomes in 81 methadone- and buprenorphine-maintained participants from two randomized trials of financial incentives for smoking cessation." | 4.91 | Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions. ( Miller, ME; Sigmon, SC, 2015) |
| " The general population model included age, hepatitis C virus infection, days of opioid used by type, number of cigarettes used daily, and the following medications used in the last 30 day of pregnancy: bupropion, antinausea medicines, benzodiazepines, antipsychotics, and gabapentin." | 4.02 | Development and Validation of a Model to Predict Neonatal Abstinence Syndrome. ( Cooper, WO; Dudley, J; Harrell, FE; Hartmann, K; Martin, PR; Patrick, SW; Slaughter, JC; Stratton, S, 2021) |
| "Pregnant smokers recruited to participate in a placebo-controlled trial of bupropion for smoking cessation provided a blood sample for measurement of NMR." | 3.96 | Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study. ( Hand, D; Kranzler, HR; Lynch, KG; Oncken, C; Schnoll, R; Tyndale, RF; Washio, Y; Zindel, LR, 2020) |
| "New treatments to combat opiate addiction are sorely needed." | 1.56 | Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats. ( Blair, G; Davis, JM; Ko, A; Levin, ED; Modarres, J; Pace, C; Rezvani, AH; Rose, JE; Wells, C, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, KY | 1 |
| Mintz, CM | 1 |
| Presnall, N | 1 |
| Bierut, LJ | 1 |
| Grucza, RA | 1 |
| Ware, OD | 1 |
| Sweeney, MM | 1 |
| Cunningham, C | 1 |
| Umbricht, A | 1 |
| Stitzer, M | 1 |
| Dunn, KE | 2 |
| Blair, G | 1 |
| Wells, C | 1 |
| Ko, A | 1 |
| Modarres, J | 1 |
| Pace, C | 1 |
| Davis, JM | 1 |
| Rezvani, AH | 1 |
| Rose, JE | 1 |
| Levin, ED | 1 |
| Kranzler, HR | 1 |
| Washio, Y | 1 |
| Zindel, LR | 1 |
| Lynch, KG | 1 |
| Hand, D | 1 |
| Tyndale, RF | 1 |
| Oncken, C | 1 |
| Schnoll, R | 1 |
| McKendrick, G | 1 |
| Sharma, S | 1 |
| Sun, D | 1 |
| Randall, PA | 1 |
| Graziane, NM | 1 |
| Patrick, SW | 1 |
| Slaughter, JC | 1 |
| Harrell, FE | 1 |
| Martin, PR | 1 |
| Hartmann, K | 1 |
| Dudley, J | 1 |
| Stratton, S | 1 |
| Cooper, WO | 1 |
| Miller, ME | 2 |
| Sigmon, SC | 3 |
| Meyer, AC | 1 |
| Saulsgiver, K | 1 |
| Badger, GJ | 1 |
| Heil, SH | 1 |
| Higgins, ST | 1 |
| Klein, JW | 1 |
| Saulsgiver, KA | 1 |
| Levin, FR | 1 |
| Evans, SM | 1 |
| Brooks, DJ | 1 |
| Kalbag, AS | 1 |
| Garawi, F | 1 |
| Nunes, EV | 1 |
| Johnson, BA | 1 |
| Margolin, A | 1 |
| Kosten, T | 2 |
| Petrakis, I | 1 |
| Avants, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Incentive-based Smoking Cessation for Methadone Patients[NCT00718835] | Phase 2 | 170 participants (Anticipated) | Interventional | 2007-06-30 | Completed | ||
| Treatment of Adult ADHD in Methadone Patients[NCT00061087] | Phase 2/Phase 3 | 115 participants (Actual) | Interventional | 1998-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for bupropion and Opioid-Related Disorders
| Article | Year |
|---|---|
Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.
Topics: Analgesics, Opioid; Bupropion; Forecasting; Humans; Methadone; Opioid-Related Disorders; Randomized | 2015 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug T | 2016 |
3 trials available for bupropion and Opioid-Related Disorders
| Article | Year |
|---|---|
Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
Topics: Bupropion; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Humans; Male; Methadone; | 2023 |
Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Analgesics, Opioid; Breath Tests; Bupropion; Carbon Monoxi | 2016 |
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Topics: Adult; Algorithms; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Attention Deficit D | 2006 |
8 other studies available for bupropion and Opioid-Related Disorders
| Article | Year |
|---|---|
Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.
Topics: Analgesics, Opioid; Buprenorphine; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; | 2022 |
Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Bupropion; Dextromethorphan; Disease Models, Animal; | 2020 |
Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study.
Topics: Analgesics, Opioid; Bupropion; Cotinine; Female; Humans; Methadone; Nicotine; Opiate Substitution Tr | 2020 |
Acute and chronic bupropion treatment does not prevent morphine-induced conditioned place preference in mice.
Topics: Analgesics, Opioid; Animals; Bupropion; Conditioning, Psychological; Dopamine Uptake Inhibitors; Dru | 2020 |
Development and Validation of a Model to Predict Neonatal Abstinence Syndrome.
Topics: Adult; Analgesics; Antiemetics; Antipsychotic Agents; Benzodiazepines; Bupropion; Female; Gabapentin | 2021 |
Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients.
Topics: Analgesics, Opioid; Behavior Therapy; Bupropion; Female; Humans; Male; Motivation; Opiate Substituti | 2011 |
Pills for speedballing or cocaine dependence.
Topics: Bupropion; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Humans; Methadone; Narcotics; Opio | 2006 |
An open pilot study of bupropion and psychotherapy for the treatment of cocaine abuse in methadone-maintained patients.
Topics: Antidepressive Agents; Bupropion; Cocaine; Humans; Methadone; Opioid-Related Disorders; Propiophenon | 1990 |